Physical activity found to boost mental health in women with chronic pelvic pain disorders
A new Mount Sinai study provides compelling evidence that exercise can significantly help the mental well-being of millions ...
Click2Houston8h
Doctors at NexGenEsis Healthcare say they are revolutionizing pain relief with regenerative medicine
Dr. Abhishek Reddy and Dr. Joe Fuhrman stop by Houston Life to discuss their innovative approach to pain management.
Use of strong synthetic opioids during surgery linked to poor 'pain experience'
The use of powerful synthetic opioids, such as sufentanil and remifentanil, during surgery is linked to a subsequent poor ...
Painkillers don’t work as well for women. Here’s why.
The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.
AFP1d
Vertex Announces FDA Approval of JOURNAVXâ„¢ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
“I believe JOURNAVX could redefine the management of pain and become a foundational treatment option for people with all types of moderate-to-severe acute pain, where options aside from opioids ...
BioSpace2d
Vertex’s Journavx Changes the Pain Treatment Landscape But Opioids Here to Stay
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
WRIC2d
FDA approves first opioid-free painkiller in over two decades
The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...
Vertex Pharmaceuticals Incorporated (VRTX): Among Renaissance Technologies Portfolio’s Top Stock Picks
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
Facebook | The Stute5d
FDA approves first-of-its-kind non-opioid pain medication
On January 30, 2025, the US FDA approved Journavx (suzetrigine) 50mg oral tablets to use in the treatment of moderate to severe acute pain, making it the first non-opioid analgesic of its class to ...
JD Supra5d
FDA Approved Journavx, a Non-Opioid Drug for Pain Management
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
The neuroscience of how the brain ‘switches off’ pain
Developing new painkilling treatments relies on the work of pain researchers to unravel the intricate neuronal circuitry and function.
GoodNewsNetwork9d
FDA Approves Opioid-free Pain Medication That Finally Delivers Relief Without Addiction
The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...